Medistim ASASTU:MD1 92 Market Cap is €366.92 Mil as of Jul. 02, 2026. GuruFocus rates STU:MD1 with a GF Score™ of 92/100 and a GF Value™ of €22.51. The stock has 1 warning sign investors should review. Among 869 Medical Devices & Instruments companies, Medistim ASA ranks better than 66.74% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medistim ASA's share price for the quarter that ended in Mar. 2026 was €18.45. Medistim ASA's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 18.28 Mil. Therefore, Medistim ASA's market cap for the quarter that ended in Mar. 2026 was €337.32 Mil.
Medistim ASA's quarterly market cap
increased
from Sep. 2025 (€352.67 Mil) to Dec. 2025 (€385.77 Mil) but then
declined
from Dec. 2025 (€385.77 Mil) to Mar. 2026 (€337.32 Mil).
Medistim ASA's annual market cap
declined
from Dec. 2023 (€348.27 Mil) to Dec. 2024 (€229.84 Mil) but then
increased
from Dec. 2024 (€229.84 Mil) to Dec. 2025 (€385.77 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medistim ASA's Enterprise Value for Today is €351.57 Mil.
Medistim ASA (STU:MD1) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medistim ASA Market Cap Related Terms
Medistim ASA Market Cap Historical Data
* Premium members only.
The historical data trend for Medistim ASA's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medistim ASA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistim ASA Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Market Cap distribution charts can be found below:
* The bar in red indicates where Medistim ASA's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medistim ASA's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistim ASA (STU:MD1) has a Market Cap of €366.92 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medistim ASA and its competitors. According to the industry distribution chart, Medistim ASA ranks #289 out of 869 companies in the Medical Devices & Instruments industry, placing it in the top 33.3%.
Is Medistim ASA's Market Cap too high?
Medistim ASA's current Market Cap is €366.92 Mil. Based on the distribution chart, Medistim ASA ranks #289 out of 869 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medistim ASA has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medistim ASA ranks #289 out of 869 companies for Market Cap. This puts Medistim ASA in the upper half of its industry. The industry median Market Cap is 119.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 119.28, based on 869 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medistim ASA and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 119.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistim ASA's current Market Cap is €366.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Medistim ASA (STU:MD1) has a current Market Cap of €366.92 Mil. The stock's GF Value™ is €22.51, compared to a current price of €19.95 — trading 11.4% below its estimated fair value. The current Market Cap is €366.92 Mil. Medistim ASA's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Medistim ASA (STU:MD1), the current Market Cap is €366.92 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medistim ASA (STU:MD1) Overvalued in 2026?
Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued.
The current stock price of €19.95 is trading 11.4% below its estimated GF Value™ of €22.51.
Key valuation signals for STU:MD1:
Market Cap: €366.92 Mil
GF Value™: €22.51 vs. price of €19.95 (11.4% below fair value)
No single metric tells the full story. See the STU:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
92GF Score
Get the complete analysis for STU:MD1
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MD1 has been successfully added to your 
